- Home
- ARMP
as 07-26-2024 4:00pm EST
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | LOS ANGELES |
| Market Cap: | 96.5M | IPO Year: | N/A |
| Target Price: | $7.00 | AVG Volume (30 days): | 8.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.27 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.90 - $5.26 | Next Earning Date: | 08-12-2024 |
| Revenue: | $4,699,000 | Revenue Growth: | -7.28% |
| Revenue Growth (this year): | 2.21% | Revenue Growth (next year): | -39.40% |
Latest Armata Pharmaceuticals Inc. News
ARMP Breaking Stock News: Dive into ARMP Ticker-Specific Updates for Smart Investing
PR Newswire
16 days ago
Armata Pharmaceuticals Announces Completion of Enrollment of Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection
PR Newswire
16 days ago
Armata Pharmaceuticals Announces Presentation at Viruses of Microbes 2024
Business Wire
2 months ago
Net Asset Value(s)
GlobeNewswire
2 months ago
GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials
![[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)](https://cdn.finquota.com/news/08105881-4f1f-4625-88fc-0d2aecc207aa.png)
GlobeNewswire
2 months ago
[Latest] Global Virtual Reality In Gaming Market Size/Share Worth USD 103,244.7 Million by 2033 at a 16.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
Business Wire
2 months ago
CCF Group Successful €225m AT1 Issuance
Insider Monkey
2 months ago
Should You Hold 908 Devices (MASS)?
GlobeNewswire
2 months ago
Bangladesh Ecommerce Market Report 2024, Featuring Daraz Bangladesh, Chaldal, Evaly, Pickaboo and Ajkerdeal - Forecasts to 2028
Compare ARMP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ARMP Armata Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.